Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2016
At a glance
- Drugs Pemetrexed (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 07 Mar 2016 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 02 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.